KOH Examination (Sputum) Explained: Fungal Detection, Procedure, Results & Report Reading (India 2026) | KOH एग्जामिनेशन स्पटम गाइड
KOH Examination (Sputum) Explained: Fungal Detection, Procedure, Results & Report Reading (India 2026)
KOH एग्जामिनेशन स्पटम गाइड: Fungal Detection, Procedure, Aspergillus vs Candida vs Mucor, Results Reading — पूरी जानकारी
Your doctor has ordered a "KOH examination of sputum" — or your lab report has come back with "KOH Examination: Fungal elements seen — septate hyphae" or "No fungal elements detected." You are trying to understand what this test is, why it was ordered, and what the result means for your lung health. The KOH (Potassium Hydroxide) Examination is a rapid, inexpensive, direct microscopic test that detects the presence of fungal elements (hyphae, spores, yeast cells) in a sputum sample. It is the first-line investigation for pulmonary fungal infections — which are increasingly common in India given the high burden of diabetes, tuberculosis treatment, steroid use, and immunocompromised conditions. India has an estimated burden of 1.5–2 million cases of serious fungal infection annually — and pulmonary aspergillosis, mucormycosis (the "black fungus" that gained widespread attention during the COVID-19 pandemic), and pulmonary candidiasis all begin with respiratory symptoms that may first be investigated through sputum KOH examination. This guide explains the KOH test completely — the chemistry, the procedure, what is looked for under the microscope, and how to interpret every possible result.
For related respiratory investigations, see our guides on the CBC (for eosinophilia and leucocytosis). For reading lab reports generally, see our beginner's guide to blood test reports.
Doctor ने "KOH examination of sputum" order किया — या report में "Fungal elements seen — septate hyphae" या "No fungal elements detected" आया है। KOH (Potassium Hydroxide) Examination = rapid, inexpensive, direct microscopic test जो sputum में fungal elements (hyphae, spores, yeast cells) detect करता है। Pulmonary fungal infections की first-line investigation। India में 1.5–2 million serious fungal infections annually — diabetes, TB treatment, steroids, immunocompromised conditions। Pulmonary aspergillosis, mucormycosis ("black fungus"), candidiasis — respiratory symptoms से शुरू। यह guide KOH test completely explain करती है।Table of Contents / विषय सूची
- What Is KOH Examination? / KOH Examination क्या है?
- Why Is It Ordered? Clinical Indications
- The KOH Procedure — Step by Step
- Sputum Collection — The Most Critical Step
- Fungal Morphology Under the Microscope
- Reading Your KOH Report / रिपोर्ट कैसे पढ़ें
- India Context — Major Pulmonary Fungal Infections
- Limitations of KOH Examination
- Sample Collection Checklist / सैंपल Collection की तैयारी
- Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
What Is KOH Examination?
The KOH (Potassium Hydroxide) Examination is a direct microscopic technique used in clinical microbiology to detect fungal elements in biological samples. A 10–20% aqueous solution of potassium hydroxide is mixed with the clinical specimen — in this case sputum — and the preparation is examined under a light microscope. KOH acts as a clearing agent: it dissolves the background organic material (human cells, mucus, proteins) while leaving intact the chitin-rich cell walls of fungal elements, making them clearly visible against a cleared background.
KOH (Potassium Hydroxide) Examination = direct microscopic technique। Biological samples में fungal elements detect करने के लिए। 10–20% KOH aqueous solution + clinical specimen (sputum) → light microscope examination। KOH = clearing agent: background organic material (human cells, mucus, proteins) dissolve करता है + fungal chitin-rich cell walls intact रखता है → clear background पर fungal elements visible।- Standard KOH (10–20% KOH in water): The basic preparation — used at most district and government hospitals. Provides clearing in 15–30 minutes at room temperature, or faster with gentle warming. Fungal elements appear as refractile (light-bending), colourless or faintly greenish structures against a cleared background. Sensitivity: approximately 50–75% for most pulmonary fungal infections, depending on fungal burden and sample quality.
- KOH + Calcofluor White (CFW): Calcofluor White is a fluorescent dye (optical brightener) that selectively binds to chitin and cellulose in fungal cell walls. KOH + CFW preparation requires a fluorescence microscope (available at tertiary hospital labs and NABL reference labs). Under UV light, fungal elements fluoresce bright apple-green or blue-white — dramatically increasing sensitivity to 80–90%. This is the preferred preparation in labs with fluorescence microscopy capability.
- KOH + DMSO (Dimethyl sulfoxide): DMSO accelerates KOH clearing — the preparation is ready for examination in 5–10 minutes rather than 15–30 minutes. Useful when a very rapid result is needed in an emergency setting (suspected mucormycosis with rapidly spreading infection).
- KOH + India Ink: India Ink is added to detect the polysaccharide capsule of Cryptococcus neoformans — the cryptococcal capsule appears as a clear halo around the yeast cell against the black India Ink background. Used specifically when cryptococcal infection is suspected (typically in HIV/AIDS patients).
Why Is It Ordered? Clinical Indications
The most common clinical trigger for KOH examination of sputum in Indian practice is a patient with persistent productive cough (lasting more than 2–4 weeks) who has not responded to one or more courses of standard antibacterial antibiotics. When bacterial pneumonia treatment fails to produce expected improvement, fungal pneumonia enters the differential diagnosis — particularly in patients with risk factors for fungal infection. The sputum KOH is the first and simplest investigation to check for fungal elements before proceeding to more expensive or invasive investigations. Key risk factors in Indian patients that increase the priority of sputum KOH: uncontrolled or poorly controlled diabetes mellitus (particularly type 2 DM — the single most important risk factor for invasive fungal infection in India), patients receiving systemic corticosteroids (for any condition — asthma, rheumatoid arthritis, nephrotic syndrome, inflammatory bowel disease), patients who have completed or are receiving TB treatment (structural lung changes from TB create cavities that serve as ideal environments for Aspergillus colonisation — aspergilloma), and patients recently recovered from severe COVID-19 (COVID-associated pulmonary aspergillosis, CAPA).
Most common trigger: 2–4 weeks+ productive cough जो standard antibiotics से ठीक नहीं। Bacterial pneumonia treatment fail → fungal pneumonia differential। KOH = first and simplest investigation। India में key risk factors: Uncontrolled DM (T2DM — most important risk factor for invasive fungal infection)। Systemic corticosteroids (asthma, RA, nephrotic syndrome, IBD)। TB treatment/post-TB (cavities → Aspergillus colonisation/aspergilloma)। Post-severe COVID-19 (CAPA)।In immunocompromised patients, any respiratory symptom (cough, fever, breathlessness) warrants early fungal investigation — because the threshold for symptomatic pulmonary fungal infection is much lower and the consequences of delayed diagnosis are catastrophic. High-priority groups in India: HIV/AIDS patients with CD4 count below 200/µL (highest risk for Pneumocystis jirovecii pneumonia — PJP, detected by modified KOH or Giemsa stain, and cryptococcal pneumonia — KOH + India Ink); patients receiving chemotherapy for haematological malignancies (acute leukaemia, lymphoma — highest risk for invasive pulmonary aspergillosis); solid organ transplant recipients on immunosuppression; patients on long-term high-dose corticosteroids (above 20 mg/day prednisolone for more than 3 weeks); and patients with primary immunodeficiencies. In immunocompromised patients, a negative KOH does not exclude fungal infection — culture, galactomannan assay, beta-glucan, and HRCT chest are also required.
Immunocompromised patients: any respiratory symptom → early fungal investigation। Delayed diagnosis = catastrophic। High-priority groups India में: HIV/AIDS (CD4 <200 — PJP, cryptococcal pneumonia)। Haematological malignancy chemotherapy (acute leukaemia, lymphoma — invasive pulmonary aspergillosis highest risk)। Solid organ transplant। Long-term high-dose steroids (>20 mg/day prednisolone >3 weeks)। Primary immunodeficiencies। Immunocompromised में negative KOH = exclude नहीं — culture + galactomannan + beta-glucan + HRCT chest भी।The COVID-19 pandemic brought pulmonary fungal infections — particularly COVID-associated pulmonary aspergillosis (CAPA) and COVID-associated mucormycosis (CAM) — to widespread clinical awareness in India. Indian patients with severe COVID-19 requiring ICU admission, mechanical ventilation, or high-dose corticosteroids had dramatically elevated rates of secondary pulmonary fungal infection. Post-COVID patients with persistent respiratory symptoms (continuing cough, worsening breathlessness, haemoptysis) beyond the expected COVID recovery period — particularly if they received systemic corticosteroids during their COVID illness — should have sputum KOH examination as part of their respiratory workup. The mucormycosis outbreak in India during the second COVID wave (April–June 2021) disproportionately affected diabetic patients who had received corticosteroids for COVID management — a combination that created near-ideal conditions for Mucor/Rhizopus germination and invasion.
Post-COVID: CAPA (COVID-associated pulmonary aspergillosis) और CAM (COVID-associated mucormycosis)। Severe COVID (ICU, mechanical ventilation, high-dose steroids) → secondary pulmonary fungal infection dramatically elevated। Post-COVID persistent symptoms (persistent cough, worsening breathlessness, haemoptysis) + systemic steroids during COVID → sputum KOH workup में। Second COVID wave mucormycosis outbreak (April–June 2021): diabetic patients + corticosteroids = near-ideal Mucor/Rhizopus germination conditions।India carries 26% of the global tuberculosis burden — and a significant proportion of TB survivors develop post-TB structural lung disease including pulmonary cavities (residual air-filled spaces in the lung parenchyma where active TB destroyed lung tissue). These cavities are the ideal environment for Aspergillus colonisation — Aspergillus spores, which are ubiquitous in the Indian environment (soil, decaying vegetation, construction sites, mouldy food), germinate and grow within these pre-existing lung cavities forming an "aspergilloma" — a fungal ball. Aspergilloma presents with: chronic cough, recurrent haemoptysis (blood in sputum — often the alarming presenting feature that brings the patient to attention), and a characteristic "crescent sign" (air crescent around a round fungal ball) on chest X-ray or CT. Sputum KOH in aspergilloma typically reveals septate hyphae with acute-angle (45°) branching — the characteristic Aspergillus morphology. Sputum KOH is an important and accessible screening investigation for any post-TB patient with haemoptysis or worsening respiratory symptoms.
India में 26% global TB burden। Post-TB structural lung disease: pulmonary cavities (TB-destroyed lung tissue)। Aspergillus spores (ubiquitous — soil, decaying vegetation, construction sites) → cavity में germinate → aspergilloma (fungal ball)। Presentation: chronic cough, recurrent haemoptysis (alarming!), chest X-ray में "crescent sign" (air crescent around fungal ball)। KOH: septate hyphae, 45° acute-angle branching = Aspergillus morphology। Post-TB patient में haemoptysis/worsening symptoms → sputum KOH screening।The KOH Procedure — Step by Step
The KOH examination is performed in the microbiology laboratory on the freshly submitted sputum sample. Understanding the procedure helps patients appreciate why sample quality is critical — and why the 30–60-minute wait for results is genuinely rapid for microbiology:
KOH examination microbiology laboratory में freshly submitted sputum sample पर perform होती है। Procedure समझना patients को sample quality importance appreciate करने में help करता है।| Step | Action | Why It Matters |
|---|---|---|
| 1 | Macroscopic assessment of sputum | The microbiologist assesses the sputum sample visually: Is it mucoid (thick, sticky — from lower respiratory tract)? Mucopurulent (mucus + pus — indicates inflammation)? Purulent (predominantly pus — most likely to be lower respiratory tract)? Salivary (watery, frothy — from upper mouth, not useful)? Only mucoid, mucopurulent, or purulent samples are accepted. Salivary samples are rejected and the patient asked to re-submit. |
| 2 | Sample selection — the most infected-looking portion | From the collected sputum, the microbiologist selects the most purulent or mucoid portion using a loop or sterile wooden stick — this is statistically most likely to contain any fungal elements present. The watery portion is discarded. |
| 3 | Preparation of KOH mount on glass slide | A small amount of selected sputum is placed on a clean glass slide. One to two drops of 10–20% KOH solution are added and mixed thoroughly with the sputum using the tip of the dropper or a needle. A glass coverslip is gently placed over the preparation. |
| 4 | Clearing — waiting for KOH to work | The slide is left at room temperature for 15–30 minutes (or very gently warmed over a spirit lamp for 5 minutes — not boiled) to allow the KOH to dissolve the background cellular and mucoid material. The preparation becomes progressively more transparent as clearing proceeds. |
| 5 | Microscopic examination | The cleared preparation is examined systematically under a light microscope: low power (10× objective) first to survey the entire slide; then high-dry power (40× objective) to examine specific areas in detail. The microbiologist scans the entire coverslip area systematically — not just one spot — to avoid missing rare fungal elements. Oil immersion (100× objective) is used if yeast cells need further characterisation. |
| 6 | Reporting | If fungal elements are seen: the type (hyphae/pseudohyphae/yeast/spores), morphological characteristics (septate vs aseptate, branching angle, width), and abundance (rare/few/moderate/many) are recorded. Tentative fungal genus is suggested. If no fungal elements: "No fungal elements detected" is reported. The report notes whether the sample was adequate (cellular) or inadequate (salivary). |
Sputum Collection — The Most Critical Step
- The problem: In clinical practice across India, a significant proportion of specimens submitted as "sputum" for KOH examination are in fact saliva — oral secretions containing squamous epithelial cells from the mouth lining, not respiratory secretions from the lungs. A salivary sample will never contain pulmonary fungal elements even if severe fungal pneumonia is present — because the sample does not represent the lung.
- Early morning sample is best: Overnight respiratory secretions accumulate and concentrate in the bronchi during sleep — making the first morning sputum the highest-yield specimen for detecting any respiratory pathogen (fungi, bacteria, acid-fast bacilli). The patient should NOT eat or drink anything (including water) before collecting the morning sample. After collecting, the sample should be transported to the lab within 2 hours — do not refrigerate sputum (cold slows the KOH clearing reaction).
- The deep cough technique — mandatory: Rinse the mouth with plain water (to reduce oral contamination). Take 3–4 deep slow breaths. On the third deep breath, hold briefly and then cough forcefully and deeply from the chest (not a throat-clearing cough). Expectorate (spit) directly into the wide-mouth sterile container — not on tissue paper first. A true productive cough from the lungs feels different from a throat-clearing — the patient feels it coming from deep in the chest.
- If the patient cannot produce sputum (dry cough or weak cough): Nebulised hypertonic saline (3–5% NaCl) administered by a trained nurse for 15–20 minutes can induce productive sputum from patients unable to expectorate naturally — this is called "induced sputum" and is particularly useful in immunocompromised patients with suspected Pneumocystis jirovecii pneumonia where sputum is typically scant. Available at tertiary hospital pulmonology departments.
- Bronchoalveolar lavage (BAL): For patients who cannot produce sputum and in whom invasive fungal infection is strongly suspected, BAL (bronchoscopic washing of the lower airways) provides a high-quality lower respiratory specimen — the gold standard for pulmonary fungal diagnosis. KOH examination of BAL fluid has much higher sensitivity than KOH of expectorated sputum. Available at bronchoscopy units of tertiary hospitals.
Fungal Morphology Under the Microscope
The most important KOH morphological pattern to recognise: septate hyphae (hyphae with clearly visible cross-walls/septa dividing them into compartments) of uniform diameter (3–6 µm), branching at acute angles (approximately 45°). This pattern is characteristic of Aspergillus species — the most important mould pathogen in the world and the most commonly detected fungal pathogen in sputum KOH in Indian tertiary hospitals. Key Aspergillus species in India: Aspergillus fumigatus (most common cause of invasive pulmonary aspergillosis — IPA and CAPA); A. flavus (particularly relevant in Indian climate — also produces aflatoxin); A. niger (causes aspergilloma, associated with outer ear infection); A. terreus (increasingly recognised, resistant to amphotericin B). KOH cannot definitively distinguish between Aspergillus species — culture is required for species-level identification and antifungal susceptibility. The KOH result of "septate hyphae, acute-angle branching" should prompt immediate initiation of empirical antifungal therapy (voriconazole first-line for IPA) in the right clinical context, without waiting for culture.
KOH में most important pattern: septate hyphae (cross-walls/septa visible) + uniform diameter (3–6 µm) + acute-angle (~45°) branching = Aspergillus। India में most commonly detected mould pathogen। Species: A. fumigatus (IPA, CAPA), A. flavus (Indian climate), A. niger (aspergilloma, ear), A. terreus (amphotericin B resistant)। KOH species distinguish नहीं — culture required। "Septate hyphae, acute-angle branching" → immediate empirical antifungal (voriconazole first-line) without waiting for culture।Aseptate (no cross-walls) or sparsely septate, wide (5–15 µm), ribbon-like, thin-walled hyphae with irregular, right-angle (approximately 90°) branching pattern = Mucorales (Mucor, Rhizopus, Lichtheimia/Absidia, Cunninghamella). This KOH pattern is a medical emergency. Mucormycosis is a rapidly progressive, highly invasive, angioinvasive fungal infection with mortality rates of 50–80% even with treatment. The wide, ribbon-like aseptate hyphae on KOH are the most distinctive feature separating Mucorales from Aspergillus — and this distinction fundamentally changes antifungal management: voriconazole (effective for Aspergillus) has NO activity against Mucorales. The only effective antifungals against Mucorales are liposomal amphotericin B (first-line) and isavuconazole/posaconazole (adjuncts). When aseptate wide hyphae are seen in sputum KOH in a diabetic or immunocompromised patient — treat this as a medical emergency. Alert the clinical team immediately, initiate liposomal amphotericin B, and arrange urgent HRCT chest and ENT evaluation (mucormycosis often starts in the sinuses and invades into the lungs/brain).
Aseptate (no cross-walls) या sparsely septate, wide (5–15 µm), ribbon-like, thin-walled hyphae + 90° right-angle branching = Mucorales (Mucor, Rhizopus)। MEDICAL EMERGENCY। Mucormycosis: rapidly progressive, angioinvasive, mortality 50–80%। KEY: Voriconazole (Aspergillus के लिए effective) = NO activity against Mucorales। Mucorales treatment: liposomal amphotericin B (first-line) + isavuconazole/posaconazole (adjuncts)। Diabetic/immunocompromised + aseptate wide hyphae → immediate clinical team alert + liposomal amphotericin B + urgent HRCT + ENT evaluation।Oval budding yeast cells (3–8 µm) — single yeast cells with a small bud attached, creating a "snowman" or "figure-of-eight" appearance — with or without pseudohyphae (chains of elongated yeast cells with constrictions at the junction points, resembling but not identical to true hyphae) are characteristic of Candida species. Important caveat for sputum KOH: Candida species are frequent oral commensals in healthy individuals — they are normally present in the mouth and throat without causing disease. In a sputum sample, Candida cells are very commonly detected from oral contamination during sputum collection (the sample passing through the mouth picks up oral Candida). This makes the clinical interpretation of Candida detected on sputum KOH highly context-dependent: Candida in sputum from an immunocompetent patient without other risk factors = almost always oral contamination, clinically insignificant. Candida in sputum from an intubated ICU patient, an immunocompromised patient, or in the context of a compatible clinical picture = warrants antifungal treatment discussion. Never treat Candida in sputum as pulmonary candidiasis without clinical correlation and repeat sampling.
Oval budding yeast (3–8 µm) ± pseudohyphae = Candida। Critical caveat: Candida = oral commensal — sputum collection में oral contamination pick up। Immunocompetent patient में sputum Candida = almost always oral contamination, clinically insignificant। ICU intubated patient / immunocompromised + compatible clinical picture = antifungal discussion। Sputum Candida को pulmonary candidiasis = treat नहीं without clinical correlation + repeat sampling।Large (5–20 µm), round to oval yeast cells with a prominent polysaccharide capsule — the capsule appears as a clear halo around the yeast cell on India Ink preparation (the capsule does not stain with India Ink, creating a clear ring against the black background). Cryptococcus neoformans/gattii causes pulmonary and CNS cryptococcosis — predominantly in HIV/AIDS patients with CD4 below 100/µL. Standard KOH alone may not reliably demonstrate the capsule — India Ink preparation is specifically required when Cryptococcus is suspected. Serum cryptococcal antigen (CrAg) is a rapid, highly sensitive blood test (sensitivity 99%+) that should be ordered simultaneously in any suspected cryptococcal case. In India, cryptococcal meningitis (not pulmonary cryptococcosis) is the more common clinical presentation — any HIV patient presenting with headache and meningism should have lumbar puncture with India Ink examination of CSF alongside serum CrAg.
Large (5–20 µm), round yeast + prominent polysaccharide capsule (India Ink में clear halo = capsule) = Cryptococcus neoformans/gattii। HIV/AIDS में CD4 <100/µL → pulmonary और CNS cryptococcosis। Standard KOH alone: capsule reliably demonstrate नहीं। India Ink preparation specifically required। Serum CrAg (cryptococcal antigen): rapid, 99%+ sensitivity — simultaneously order। India में: cryptococcal meningitis more common (CSF India Ink + serum CrAg)।Reading Your KOH Report / रिपोर्ट कैसे पढ़ें
| Report Statement | What It Means | Clinical Implication & Action |
|---|---|---|
| No fungal elements detected / KOH negative | No hyphae, spores, or yeast cells seen in the examined preparation | Does NOT rule out fungal infection — KOH sensitivity is 50–75%. If clinical suspicion remains high, proceed to sputum fungal culture, galactomannan, beta-glucan, and HRCT chest. Repeat with a better quality early morning sputum sample. |
| Septate hyphae seen / Fungal hyphae (septate) with acute-angle branching | Aspergillus-pattern hyphae detected in the sample | Consistent with Aspergillus species (or other septate moulds — Fusarium, Scedosporium). Clinical correlation essential. In immunocompromised patient with compatible HRCT: begin voriconazole empirically. Order serum galactomannan and sputum fungal culture for confirmation. |
| Aseptate/broad hyphae seen / Wide aseptate hyphae with right-angle branching | Mucorales-pattern hyphae — emergency finding | Medical emergency. Alert clinical team immediately. Initiate liposomal amphotericin B. Urgent HRCT chest and ENT evaluation. Surgical debridement may be required. Do NOT use voriconazole — ineffective against Mucorales. |
| Budding yeast cells seen / Yeast cells with pseudohyphae | Candida-pattern — most commonly oral contamination in sputum | Context-dependent. Immunocompetent outpatient: likely oral contamination, repeat with better quality sample. ICU/immunocompromised patient: may be significant. Correlation with clinical picture, Candida culture, and β-D-glucan assay required before treating. |
| Sample inadequate / Salivary sample — please resubmit | Submitted specimen is saliva (squamous epithelial cells predominate), not lower respiratory sputum | Resubmit early morning deep-cough sputum. Review collection instructions with patient. Consider induced sputum or BAL if patient cannot expectorate adequately. |
| Fungal spores seen / Conidia seen | Fungal spores (reproductive structures) detected without accompanying hyphae | May represent environmental contamination (Aspergillus and Mucor spores are ubiquitous in Indian air) rather than active pulmonary infection. Repeat with fresh sample, correlation with clinical picture and sputum culture required. |
India Context — Major Pulmonary Fungal Infections
India has approximately 70 times the global per-capita rate of mucormycosis — making it the worldwide centre of this life-threatening infection. Before COVID-19, India already had the world's highest mucormycosis burden, driven by the extraordinary prevalence of diabetes (77 million diabetics), which creates systemic immunosuppression and elevated available iron (from hyperglycaemia-induced reduction of transferrin iron-binding capacity) that directly fuels Mucor/Rhizopus germination and hyphal invasion. The COVID-19 pandemic amplified this burden catastrophically: in April–June 2021, India reported over 47,000 cases of COVID-associated mucormycosis in a matter of weeks — a global emergency. The triad responsible: diabetes + corticosteroid use for COVID + COVID-induced hyperglycaemia. On KOH examination, the aseptate wide-ribbon hyphae with right-angle branching are the critical diagnostic finding — this morphological finding in the right clinical context should trigger immediate life-saving intervention without waiting for culture confirmation. Treatment delay of even 6–12 hours can mean the difference between surgical debridement and fatal dissemination.
India में mucormycosis = global per-capita rate का 70×। Before COVID: world's highest burden (77 million diabetics — hyperglycaemia → iron availability ↑ → Mucor/Rhizopus germination fuel)। COVID amplified: April–June 2021, India में 47,000+ cases। Triad: diabetes + corticosteroids + COVID-induced hyperglycaemia। KOH: aseptate wide-ribbon hyphae + right-angle branching = critical finding → immediate intervention without waiting for culture। 6–12 hours delay = surgical debridement vs fatal dissemination।Aspergillus fumigatus spores are ubiquitous in the Indian environment — found in soil, decaying organic matter, construction site dust, mouldy food, and bioaerosols from composting. Most healthy individuals inhale Aspergillus spores daily without consequence. Disease occurs when host defences are impaired. The three clinically distinct forms seen in Indian patients:
- Aspergilloma (fungal ball): Non-invasive colonisation of pre-existing pulmonary cavity (most commonly post-TB, bronchiectasis, or old sarcoidosis cavity). Presents with haemoptysis. KOH: septate hyphae. Treatment: surgery if haemoptysis severe or recurrent; itraconazole/voriconazole for inoperable cases.
- Allergic Bronchopulmonary Aspergillosis (ABPA): An allergic (IgE-mediated) hypersensitivity reaction to Aspergillus antigens in asthma or cystic fibrosis patients — not a direct infection. Presents with worsening asthma, eosinophilia, elevated Total IgE, and Aspergillus-specific IgE. KOH may show hyphae or be negative. Diagnosed by specific immunological criteria; treated with corticosteroids and itraconazole.
- Invasive Pulmonary Aspergillosis (IPA): Life-threatening angioinvasive infection in severely immunocompromised patients (haematological malignancy, bone marrow transplant, prolonged steroid use). Mortality 30–80% even with treatment. KOH: septate hyphae. Serum galactomannan and HRCT (halo sign) are key investigations. Treatment: voriconazole (first-line).
Pneumocystis jirovecii (formerly Pneumocystis carinii — hence the acronym PCP also seen in older literature) is a yeast-like fungus that causes severe pneumonia in HIV/AIDS patients with CD4 count below 200/µL — it is the most common opportunistic infection in HIV patients globally and in India. PJP presents with: progressive dyspnoea (breathlessness) over days to weeks, dry cough (minimal or no sputum), low-grade fever, and markedly reduced oxygen saturation (SpO2) disproportionate to the apparent auscultatory findings. Chest X-ray shows bilateral perihilar "ground glass" shadowing; HRCT shows bilateral ground-glass opacification. Standard KOH examination alone is not reliable for PJP detection — Pneumocystis cysts are small (5–8 µm) and may not clear well with standard KOH. Specific stains required: Gomori Methenamine Silver (GMS — stains the cyst walls black), Giemsa (stains the intracystic bodies), or immunofluorescence with anti-Pneumocystis antibody (the most sensitive). Induced sputum or BAL is required for adequate sample quality. Treatment: high-dose co-trimoxazole (TMP-SMX) for 21 days; severe PJP also requires systemic corticosteroids.
PJP (Pneumocystis jirovecii): HIV/AIDS में most common opportunistic infection। CD4 <200/µL। Progressive dyspnoea, dry cough, low-grade fever, SpO2 markedly reduced। CXR: bilateral perihilar ground glass। HRCT: bilateral ground-glass opacification। Standard KOH: NOT reliable for PJP। Specific stains: GMS (cyst walls black), Giemsa (intracystic bodies), immunofluorescence। Induced sputum या BAL। Treatment: high-dose co-trimoxazole (TMP-SMX) 21 days + systemic steroids (severe)।Limitations of KOH Examination
- Sensitivity: only 50–75% for most pulmonary fungal infections. A negative KOH does not rule out fungal infection — 25–50% of true fungal infections will be missed by KOH alone, particularly when the fungal burden in the sputum is low (early infection, or when the infection is deep in the lung parenchyma and not yet communicating with the airways). This low sensitivity is the most important limitation in clinical practice.
- Cannot identify to species level. KOH can suggest a fungal genus based on morphology (Aspergillus-pattern, Mucorales-pattern, Candida-pattern) but cannot definitively identify the species. Aspergillus fumigatus and Aspergillus terreus cannot be distinguished on KOH — but A. terreus is resistant to amphotericin B, making species identification critically important for treatment. Fungal culture (1–6 weeks) is required for definitive species identification and antifungal susceptibility testing.
- Cannot distinguish colonisation from invasive infection. Aspergillus in sputum from a patient with COPD or post-TB bronchiectasis may represent simple airway colonisation (non-invasive, no treatment needed) or invasive pulmonary aspergillosis (life-threatening, antifungal treatment essential). KOH cannot make this distinction — HRCT chest, serum galactomannan, and clinical context determine whether the finding represents colonisation or invasion.
- Environmental contamination is a source of false positives. Aspergillus and Mucor spores are extremely abundant in the Indian environment — in air, on surfaces, in food. The sputum sample can be contaminated by environmental fungal spores during collection or transport, producing a false-positive KOH result (spores seen but no active infection). Repeat sampling and correlation with clinical picture are essential when spores alone are seen without accompanying hyphal elements.
- PJP is not reliably detected by standard KOH. Pneumocystis jirovecii requires specific staining techniques (GMS, Giemsa, immunofluorescence) for reliable detection. Standard KOH is inadequate for suspected PJP — order the specific stain alongside KOH in HIV patients.
Sample Collection Checklist / सैंपल Collection की तैयारी
-
Collect early morning sputum — the first expectorated sample on waking, before eating or drinking anything. Overnight respiratory secretions accumulate in the bronchi during sleep and are most concentrated in the morning. Do not eat breakfast, drink water, or use toothpaste before collection. Rinsing the mouth with plain water (without swallowing) immediately before coughing is permitted — this reduces oral bacterial and yeast contamination of the sample.
Early morning sputum — waking के बाद first expectorated sample, eating/drinking से पहले। Overnight secretions accumulate। Breakfast, water, toothpaste: collection से पहले नहीं। Plain water से mouth rinse (swallow नहीं) = permitted — oral contamination reduce। -
Use the sterile wide-mouth sputum collection container provided by the lab — do not use any household container or handkerchief. The collection container must be sterile to avoid environmental fungal contamination. The wide mouth makes direct expectoration easier. Label the container with your name, age, date, and time of collection before submitting to the lab.
Lab-provided sterile wide-mouth sputum container use करें — household container या handkerchief नहीं। Sterile = environmental fungal contamination avoid। Wide mouth = direct expectoration easier। Label: name, age, date, time of collection। -
Perform the deep cough technique correctly. Stand or sit upright. Take 3–4 slow, deep breaths in and out. On the last deep inhalation, hold for 2–3 seconds, then cough forcefully and deeply from the chest — not a gentle throat-clearing. Expectorate (spit) the sputum directly into the container. The produced material should be thick, mucoid, or purulent — not watery and clear (which indicates saliva). If you cannot produce sputum in the first attempt, rest, breathe deeply, and try again.
Deep cough technique: Upright stand/sit। 3–4 slow deep breaths। Last inhalation: 2–3 seconds hold → forceful deep chest cough (throat-clearing नहीं)। Container में directly expectorate। Produced material: thick/mucoid/purulent — watery/clear = saliva। First attempt में नहीं → rest + deep breath + retry। -
Transport to the lab within 2 hours of collection — do not refrigerate. Sputum should reach the lab while fresh: prolonged storage allows overgrowth of oral bacteria and commensal yeast (particularly Candida) that can make the KOH result misleading. Do not refrigerate sputum for KOH examination — cold temperatures slow the KOH clearing reaction and may delay result or reduce clarity. If transport is delayed beyond 2 hours, inform the lab.
Collection के 2 hours के अंदर lab transport — refrigerate नहीं। Prolonged storage → oral bacteria + commensal yeast (Candida) overgrowth → KOH result misleading। Refrigerate नहीं: cold → KOH clearing slow। 2 hours से ज़्यादा delay → lab inform। -
Inform the lab and your doctor if you have recently used antifungal medications (fluconazole, itraconazole, voriconazole, amphotericin B). Antifungal treatment reduces fungal burden in the respiratory tract, potentially producing a false-negative KOH when active infection is present but partially treated. If you are already on antifungal therapy and a KOH is being ordered to assess response — inform both the ordering physician and the lab. Ideally, the first diagnostic KOH should be obtained before antifungal therapy is initiated.
Recent antifungal medications (fluconazole, itraconazole, voriconazole, amphotericin B) → lab और doctor को inform। Antifungal treatment → fungal burden reduce → false-negative KOH possible। First diagnostic KOH: antifungal therapy initiate करने से पहले ideally। -
If you cannot produce sputum (non-productive cough), do not submit saliva — inform your doctor. Your doctor can arrange induced sputum (using nebulised hypertonic saline at the hospital pulmonology department) or bronchoalveolar lavage (BAL) via bronchoscopy for patients who cannot expectorate naturally. Submitting saliva produces a meaningless result — it is better to delay the test by one day and submit a proper sample than to submit a salivary sample that will be reported as "inadequate" or may produce a misleading false-negative.
Non-productive cough, sputum नहीं आ रहा → saliva submit नहीं → doctor inform। Doctor arrange करेगा: induced sputum (nebulised hypertonic saline, pulmonology) या BAL (bronchoscopy)। Saliva submit = meaningless result। 1 day delay + proper sample better than salivary sample = "inadequate" या false-negative।
✅ Book KOH Examination (Sputum) — Fungal Detection
KOH sputum examination requires a quality early morning deep-cough sputum sample submitted within 2 hours. Always order alongside sputum fungal culture (2–6 weeks for final result) and, where available, Gram stain and AFB smear (to simultaneously screen for bacterial and tuberculous infection). For immunocompromised patients, also order serum galactomannan and beta-D-glucan:
Affiliate link: I may earn a small commission at no extra cost to you. KOH examination is available at government hospitals, district hospitals, and NABL-accredited pathology labs across India. Always have KOH results interpreted by a qualified pulmonologist, infectious disease specialist, or clinical microbiologist alongside HRCT chest, serum galactomannan (in immunocompromised), and clinical history. Never start antifungal treatment based on KOH result alone without clinical correlation.
KOH examination + Fungal culture + Gram stain साथ order। Early morning deep-cough sputum, 2 hours transport, refrigerate नहीं। Antifungal medications → inform। Immunocompromised: + Galactomannan + Beta-D-glucan। Pulmonologist/ID specialist से HRCT + galactomannan + clinical history के साथ interpret। KOH alone पर antifungal treatment नहीं।Respiratory Health Support — Two Essential Tools
Two products relevant to respiratory health monitoring and supportive care during pulmonary illness — a steam inhaler (steam inhalation helps loosen and liquefy thick bronchial secretions, making it easier to produce a high-quality productive cough for sputum collection, and providing symptomatic relief from the congestion, cough, and airway irritation associated with respiratory fungal and non-fungal infections) and a pulse oximeter (an essential home monitoring tool for any patient with respiratory illness, allowing real-time SpO2 monitoring — critically important for detecting the oxygen desaturation that characterises pulmonary aspergillosis, PJP, and post-COVID lung involvement before it becomes clinically obvious). These products support symptomatic care and monitoring — they do not treat fungal infections. Antifungal treatment (voriconazole, liposomal amphotericin B, itraconazole) requires a physician's prescription. Never delay seeking medical care based on a normal-appearing SpO2 if respiratory symptoms are worsening.
Steam inhalation is directly relevant to the sputum KOH examination in two distinct ways. First, as a sample quality intervention: the quality of the sputum sample submitted for KOH examination is the single most important determinant of whether the test produces a meaningful result. Many patients with pulmonary fungal infection who present for KOH examination have a dry or minimally productive cough — particularly in the early stages of infection or when the infection is in the deeper parenchyma — making it difficult to expectorate adequate lower respiratory tract sputum. Steam inhalation for 10–15 minutes immediately before the collection attempt significantly increases bronchial secretion liquefaction and volume — increasing the likelihood of producing adequate, mucoid, lower respiratory tract sputum rather than salivary material. This directly improves the sensitivity of the KOH examination. Second, as a symptomatic supportive measure during recovery from respiratory illness: steam inhalation provides humidification of the airways, reduces mucociliary dysfunction from dry, inflamed bronchial mucosa, and temporarily relieves the sensation of chest congestion and breathlessness that accompanies pulmonary infections. The physiological mechanism: warm humidified air (at 40–45°C as generated by a steam inhaler) reduces the viscosity of bronchial mucus, facilitates mucociliary clearance, and opens constricted small airways through direct thermal bronchodilation. The HealthSense steam inhaler is designed for home use with a leak-proof, easy-fill design and a face mask attachment. Do not use steam inhalation in infants below 12 months (burn risk); adults with asthma should use at moderate temperature settings as very hot steam can trigger bronchospasm in sensitive individuals. Steam inhalation does not treat fungal infection and should not delay medical consultation.
Steam inhalation: KOH examination में 2 ways relevant। 1. Sample quality: Dry/minimally productive cough → inadequate sputum। Steam 10–15 minutes before collection: bronchial secretion liquefaction + volume increase → adequate mucoid sputum → KOH sensitivity improve। 2. Symptomatic support: Airways humidification, mucociliary function restore, chest congestion relief। Mechanism: warm humidified air (40–45°C) → mucus viscosity reduce → mucociliary clearance → small airway bronchodilation। HealthSense: home use, leak-proof, face mask। Infants <12 months: नहीं (burn risk)। Asthma: moderate temperature (hot steam = bronchospasm trigger)। Fungal infection treat नहीं — medical consultation delay नहीं। View on Amazon IndiaAffiliate link — small commission at no extra cost.
Pulse oximetry (SpO2 monitoring) is a critically important home monitoring tool for any patient with diagnosed or suspected pulmonary fungal infection — and for any patient recovering from COVID-19 who remains at risk for COVID-associated pulmonary aspergillosis (CAPA) or other post-COVID respiratory complications. The clinical importance: pulmonary fungal infections — particularly invasive pulmonary aspergillosis, PJP, and post-COVID lung injury — characteristically cause disproportionate hypoxaemia (reduced oxygen saturation in the blood) relative to the clinical appearance and auscultatory findings. A patient may appear relatively comfortable at rest, without obvious respiratory distress, while their SpO2 is already 88–90% — a level at which supplemental oxygen is needed and hospitalisation should be considered. This "silent hypoxaemia" is particularly well-documented in PJP (where it was called "happy hypoxia" during the COVID-19 pandemic when it was observed in SARS-CoV-2 pneumonia, a pattern shared with PJP and CAPA). Home SpO2 monitoring allows early detection of this silent oxygen desaturation before the patient is in distress — providing the critical window for early medical intervention. Specific monitoring targets for patients with confirmed or suspected pulmonary fungal infection: SpO2 above 95% at rest = acceptable. SpO2 90–95% at rest = concerning, medical review needed promptly. SpO2 below 90% at rest = hospital admission required urgently. SpO2 below 95% only on exertion (walking) but normal at rest = post-COVID or early pulmonary involvement — urgent medical review. The BPL Smart Oxy pulse oximeter provides accurate SpO2 and heart rate measurements with a reliable display, validated for use across a range of skin tones — an important consideration in India where skin pigmentation variability affects some oximeter models' accuracy. Pulse oximetry is a monitoring tool — it does not diagnose fungal infection. A normal SpO2 does not exclude pulmonary fungal disease. Any patient with confirmed or suspected invasive fungal infection must be under medical specialist supervision regardless of SpO2 reading.
Pulse oximetry (SpO2): pulmonary fungal infection + post-COVID monitoring में critically important। Invasive aspergillosis, PJP, post-COVID lung injury: disproportionate hypoxaemia (SpO2 88–90%) despite patient relatively comfortable — "silent hypoxaemia" / "happy hypoxia"। Home SpO2 monitoring = early silent desaturation detect → critical window for intervention। Targets: SpO2 >95% = acceptable। 90–95% = concerning, prompt medical review। <90% = urgent hospital। Exertion पर only <95% but rest normal = urgent medical review। BPL Smart Oxy: accurate, validated across skin tones (India में important — pigmentation variability affects some oximeters)। Monitoring tool — fungal infection diagnose नहीं। Normal SpO2 = pulmonary fungal disease exclude नहीं। Medical specialist supervision regardless of SpO2। View on Amazon IndiaAffiliate link — small commission at no extra cost.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside sputum KOH for complete pulmonary infection evaluation:
Sputum KOH के साथ ये जांचें complete pulmonary infection evaluation में order होती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
Not necessarily — a negative KOH examination does not rule out pulmonary fungal infection. The KOH examination has a sensitivity of only 50–75% for most pulmonary fungal infections — meaning that in up to 25–50% of true cases, the test will be negative. This happens for several reasons: the fungal burden in the sputum may be too low to detect (particularly in early infection, when the infection is deep in the lung parenchyma and not yet shedding elements into the airways, or in the setting of prior partial antifungal treatment); the submitted sample may have been poor quality (salivary rather than genuine sputum); and environmental conditions during transport or processing may have reduced KOH effectiveness. If clinical suspicion for fungal infection remains high (immunocompromised patient, diabetic with persistent pneumonia not responding to antibiotics, post-COVID with worsening breathlessness), the following additional investigations should be pursued alongside a repeat KOH on a new, high-quality sample: sputum fungal culture (the most sensitive but slowest — 2–6 weeks); serum galactomannan (a cell wall component of Aspergillus, very sensitive for IPA in immunocompromised patients); serum beta-D-glucan (detects most fungal infections including Aspergillus, Candida, and Pneumocystis); and HRCT chest (the imaging findings of halo sign, air-crescent sign, and cavitation are highly suggestive of pulmonary aspergillosis).
उत्तर: Necessarily नहीं — negative KOH = fungal infection rule out नहीं। Sensitivity 50–75%। 25–50% true cases में negative। Reasons: low fungal burden (early infection, deep parenchyma, partial treatment); poor quality sample (salivary); transport/processing issues। High clinical suspicion → additional: Sputum fungal culture (2–6 weeks, most sensitive)। Serum galactomannan (Aspergillus cell wall, very sensitive for IPA)। Serum beta-D-glucan (Aspergillus + Candida + PJP)। HRCT chest (halo sign, air-crescent, cavitation)।Wide aseptate hyphae on sputum KOH is indeed a medical emergency — it is the characteristic KOH morphology of Mucorales (Mucor, Rhizopus, and related species), the pathogens causing mucormycosis ("black fungus"). Mucormycosis is one of the most rapidly fatal fungal infections known — it progresses from initial tissue invasion to massive necrosis and dissemination within days. The mortality rate of pulmonary mucormycosis is 50–80% even with optimal treatment, and delays in treatment dramatically worsen outcomes. The reasons for emergency status: Mucorales are angioinvasive — they grow directly into and along blood vessel walls, causing thrombosis (blood clot) and infarction (tissue death from loss of blood supply) in the surrounding lung tissue. This angioinvasion progresses at a speed visible on daily CT scanning. Additionally, the antifungal drugs used for the most common other moulds (voriconazole for Aspergillus) have absolutely no activity against Mucorales — using voriconazole in a patient who actually has mucormycosis would be equivalent to using no antifungal at all. The effective treatment — liposomal amphotericin B — is very expensive, requires hospital admission, and has significant side effects requiring careful monitoring. Surgical debridement of infected tissue is often required alongside antifungal therapy. Every hour of delay in starting liposomal amphotericin B translates into further tissue destruction and worsened outcomes.
उत्तर: Wide aseptate hyphae = Mucorales (Mucor, Rhizopus) — mucormycosis ("black fungus")। Mortality 50–80% even with treatment। Emergency क्यों: Mucorales = angioinvasive — blood vessel walls में grow → thrombosis + infarction → tissue death। Daily CT पर visible progression speed। Voriconazole (Aspergillus के लिए) = Mucorales के against ZERO activity। Voriconazole देना = no antifungal देना। Effective treatment: liposomal amphotericin B (expensive, hospital admission, significant side effects monitoring)। Surgical debridement often required। Every hour delay = further tissue destruction।KOH examination and sputum fungal culture are complementary tests — neither replaces the other. KOH examination is a rapid (30–60 minutes), direct microscopic test that looks at the sputum sample under a microscope after KOH clearing. It can tell you immediately whether fungal elements are present and what type of morphology they show (septate vs aseptate hyphae, yeast cells) — allowing tentative genus identification (Aspergillus-pattern, Mucorales-pattern, Candida). This rapid result can guide empirical antifungal therapy that day. However, KOH cannot definitively identify the species, cannot determine antifungal susceptibility (which drugs will work), and has low sensitivity (misses 25–50% of real infections). Fungal culture involves growing the fungus from the sputum on specialised fungal growth media (Sabouraud Dextrose Agar, other media) in the incubator at the lab. Fungal growth takes 2–6 weeks — much slower than bacterial culture. Culture provides: definitive species identification (Aspergillus fumigatus vs A. terreus vs A. flavus — critically important for treatment), antifungal susceptibility testing (confirming which drugs are effective against that specific isolate), and confirmation that the KOH result was genuine rather than contamination. Always order both KOH and culture simultaneously — the KOH guides immediate treatment while waiting for the culture confirmation.
उत्तर: KOH: rapid (30–60 min), direct microscopic, fungal elements detect, morphology (septate vs aseptate, yeast) → tentative genus। That day empirical treatment guide। Sensitivity 50–75%, species identify नहीं, susceptibility नहीं। Fungal culture: specialised media (Sabouraud Dextrose Agar) पर grow। 2–6 weeks। Provides: definitive species ID (A. fumigatus vs A. terreus — treatment difference critical), antifungal susceptibility testing, contamination vs genuine confirm। Both simultaneously order: KOH → immediate treatment। Culture → confirmation + definitive species + susceptibility।A diabetic patient with persistent cough not responding to antibiotics and suspected pulmonary fungal infection will typically undergo a systematic investigation protocol. Initial investigations: sputum KOH examination (rapid direct fungal detection — result same day); sputum fungal culture (definitive identification — 2–6 weeks); HbA1c (to assess degree of glycaemic control — poorly controlled diabetes is the single most important risk factor for invasive fungal infection in India); CBC with differential (eosinophilia suggests ABPA; neutropaenia increases risk of IPA); serum Total IgE and Aspergillus-specific IgE (if ABPA is clinically suspected — worsening asthma, eosinophilia). Imaging: HRCT chest (high-resolution CT — the most important single imaging investigation for pulmonary fungal infection. Findings: halo sign — ground-glass opacity around a nodule — early IPA; air-crescent sign — crescent of air around a consolidation — later IPA; aspergilloma — rounded opacity with crescent air space in a cavity — classic aspergilloma; bilateral ground-glass opacification — PJP). Advanced investigations if IPA is suspected: serum galactomannan (Aspergillus cell wall antigen — positive in IPA in immunocompromised); serum beta-D-glucan (broader fungal marker). If mucormycosis is suspected: urgent HRCT + ENT evaluation + ophthalmology (for rhino-orbito-cerebral mucormycosis which can coexist with pulmonary involvement).
उत्तर: Diabetic suspected fungal pneumonia: Sputum KOH (same day)। Sputum fungal culture (2–6 weeks)। HbA1c (glycaemic control — poor DM = most important risk factor)। CBC with differential (eosinophilia = ABPA; neutropaenia = IPA risk)। Total IgE + Aspergillus-specific IgE (ABPA suspect में)। Imaging: HRCT chest (most important): halo sign (early IPA), air-crescent sign (later IPA), aspergilloma, bilateral ground-glass (PJP)। Serum galactomannan (IPA immunocompromised में)। Beta-D-glucan (broader)। Mucormycosis suspect: urgent HRCT + ENT + ophthalmology (rhino-orbito-cerebral involvement)।"Inadequate" or "salivary" means the specimen you submitted for KOH examination was oral secretions (saliva) rather than genuine sputum from the lower respiratory tract (bronchi and lungs). Under the microscope, a salivary sample shows many squamous epithelial cells (the large, flat cells that line the mouth) — more than 10 per low-power field — without the leucocytes (white blood cells) that would be present in true respiratory sputum. A salivary sample contains no lower respiratory tract material — it cannot possibly contain pulmonary fungal elements even if you have severe fungal pneumonia. The KOH result from a salivary sample is meaningless — it should be ignored and the test repeated. What to do: collect a new sample correctly the next morning — early morning (before any food, drink, or oral hygiene), deep forceful cough from the chest, directly into the sterile container. If you continue to have difficulty producing genuine sputum (because your cough is dry or non-productive), tell your doctor — they can arrange induced sputum (using inhaled nebulised saline at the pulmonology department to stimulate sputum production) or, if necessary, bronchoalveolar lavage (BAL) under bronchoscopic guidance, which always provides an adequate lower respiratory tract specimen.
उत्तर: "Inadequate"/"salivary" = submit किया specimen = oral secretions (saliva), lower respiratory tract sputum नहीं। Microscope में: many squamous epithelial cells (>10 per LPF), leucocytes absent। Salivary sample में lower respiratory material नहीं = fungal elements impossible। KOH result meaningless — ignore + repeat। Next morning: early morning, food/drink/oral hygiene से पहले, deep forceful chest cough, sterile container में। Dry/non-productive cough → doctor inform → induced sputum (nebulised saline) या BAL (bronchoscopy)।- ISHAM (International Society for Human and Animal Mycology) — Fungal Infection Guidelines: ISHAM — Mycology Guidelines and Educational Resources
- Indian Council of Medical Research (ICMR) — Mucormycosis Management Guidelines 2021: ICMR India — Mucormycosis Management Guidelines
- ESCMID/ISHAM/ECMM Guidelines — Aspergillosis: ESCMID — Aspergillosis Diagnosis and Management Guidelines
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. KOH examination results must be interpreted by a qualified pulmonologist, infectious disease specialist, or clinical microbiologist alongside HRCT chest, sputum fungal culture, serum galactomannan (in immunocompromised patients), and full clinical history. A negative KOH does not exclude fungal infection. Wide aseptate hyphae on sputum KOH in a diabetic or immunocompromised patient is a medical emergency requiring immediate specialist intervention — do not delay seeking care. Never start antifungal therapy without physician guidance. Liposomal amphotericin B, voriconazole, and other antifungals require specialist prescription and monitoring. Diabetic patients with poor glycaemic control are at highest risk of invasive fungal infection — maintaining HbA1c below 7% is the single most important preventive measure.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। KOH results को pulmonologist/ID specialist से HRCT + culture + galactomannan + clinical history के साथ interpret। Negative = exclude नहीं। Wide aseptate hyphae in diabetic/immunocompromised = MEDICAL EMERGENCY — immediate specialist intervention। Antifungal therapy physician guidance के बिना नहीं। Liposomal amphotericin B, voriconazole = specialist prescription + monitoring। HbA1c <7% = most important preventive measure।
Comments
Post a Comment